Economic evaluation of vedolizumab SC for the treatment of moderate-to-severe ulcerative colitis in Canada

被引：0
作者：
Fischer, A. [1 ]
Oppe, M. [2 ]
Stypa, S. [1 ]
Lukyanov, V. [3 ]
Petrakis, I. [4 ]
机构：
[1] Takeda Canada Inc, Patient Value & Access, Toronto, ON, Canada
[2] Axent Solut, Pharmacoecon, San Cristobal la Laguna, Spain
[3] IQVIA, Real World Insights, Amsterdam, Netherlands
[4] Takeda Inc, Payer Value & Patient Access, Boston, MA USA
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P424
引用
收藏
页码：S387 / S387
页数：1
相关论文
共 50 条
[21]   Cost-Effectiveness of Different Strategies for the Treatment of Moderate-to-Severe Ulcerative Colitis [J].
Wu, Bin ;
Wang, Zhenhua ;
Zhang, Qiang .
INFLAMMATORY BOWEL DISEASES, 2018, 24 (11) :2291-2302
[22]   Treatment Patterns Among Patients With Moderate-to-Severe Ulcerative Colitis in the United States [J].
DiBonaventura, Marco ;
Bargo, Danielle ;
Lucas, James ;
Bluff, Daniel ;
Hoskin, Ben ;
Salese, Leonardo ;
Cappelleri, Joseph C. ;
Quirk, Daniel .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 :S353-S353
[23]   A critical review of adalimumab for the treatment of moderate-to-severe active ulcerative colitis in children [J].
Pigneur, Benedicte ;
Ruemmele, Frank M. .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 16 (11-12) :1023-1028
[24]   Comparative efficacy of vedolizumab and infliximab in patients with moderate-to-severe ulcerative colitis: a multicenter real world cohort study [J].
Sun, Y. ;
Yang, H. .
JOURNAL OF CROHNS & COLITIS, 2025, 19 :i1555-i1555
[25]   Efficacy and Safety of Vedolizumab Combined with Upadacitinib in Moderate-to-Severe Ulcerative Colitis: A Multicenter, Prospective, Randomized Controlled Trial [J].
Wu, H. ;
Su, T. ;
Wu, L. ;
Zhi, M. ;
Yao, J. .
JOURNAL OF CROHNS & COLITIS, 2025, 19 :i195-i197
[26]   Cytomegalovirus colitis in patients with moderate-to-severe Ulcerative Colitis: diagnosis, clinical impact and treatment efficacy [J].
Melotti, L. ;
Salice, M. ;
Rinaldi, M. ;
Dussias, N. ;
Vanigli, N. ;
Scaioli, E. ;
Hrustemovic, H. Privitera ;
Rizzello, F. ;
Gionchetti, P. .
JOURNAL OF CROHNS & COLITIS, 2024, 18 :I567-I568
[27]   Medical therapy versus surgery in moderate-to-severe ulcerative colitis [J].
Fiorino, Gionata ;
Danese, Silvio ;
Giacobazzi, Giovanni ;
Spinelli, Antonino .
DIGESTIVE AND LIVER DISEASE, 2021, 53 (04) :403-408
[28]   Are We Ready for Combination Therapy in Moderate-to-Severe Ulcerative Colitis? [J].
Lee, Yeong Yeh ;
Gangireddy, Venugopalareddy ;
Khurana, Sandeep ;
Rao, Satish S. C. .
GASTROENTEROLOGY, 2014, 147 (02) :544-544
[29]   Systematic review and network meta-analysis of treatment for moderate-to-severe ulcerative colitis [J].
Trigo-Vicente, Cristina ;
Gimeno-Ballester, Vicente ;
Garcia-Lopez, Santiago ;
Lopez-Del Val, Alejandro .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (06) :1411-1419
[30]   Infliximab in the treatment of moderate-to-severe ulcerative colitis: Results of a large multicenter Italian survey [J].
Cappello, M. ;
Mazza, M. ;
Costantino, G. ;
Fries, W. ;
Privitera, A. C. ;
Mastronardi, M. ;
Bossa, F. ;
Rispo, A. ;
Castiglione, F. ;
Lauria, A. ;
Buccianti, N. ;
Marasco, R. ;
Grossi, L. ;
Principi, M. B. .
JOURNAL OF CROHNS & COLITIS, 2014, 8 :S252-S252
12345